284 related articles for article (PubMed ID: 16801448)
1. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
Clancy CJ; Huang H; Cheng S; Derendorf H; Nguyen MH
Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
[TBL] [Abstract][Full Text] [Related]
2. Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Li Y; Nguyen MH; Derendorf H; Cheng S; Clancy CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):2985-7. PubMed ID: 17517840
[TBL] [Abstract][Full Text] [Related]
3. Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.
Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):172-7. PubMed ID: 27492134
[TBL] [Abstract][Full Text] [Related]
4. Anidulafungin is fungicidal and exerts a variety of postantifungal effects against Candida albicans, C. glabrata, C. parapsilosis, and C. krusei isolates.
Nguyen KT; Ta P; Hoang BT; Cheng S; Hao B; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2009 Aug; 53(8):3347-52. PubMed ID: 19364856
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin activity against clinical isolates of fluconazole-resistant Candida.
Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
J Clin Microbiol; 2003 Dec; 41(12):5729-31. PubMed ID: 14662968
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
[TBL] [Abstract][Full Text] [Related]
7. Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.
Gil-Alonso S; Jauregizar N; Eraso E; Quindós G
PLoS One; 2015; 10(7):e0132730. PubMed ID: 26168269
[TBL] [Abstract][Full Text] [Related]
8. Effects of caspofungin against Candida guilliermondii and Candida parapsilosis.
Barchiesi F; Spreghini E; Tomassetti S; Della Vittoria A; Arzeni D; Manso E; Scalise G
Antimicrob Agents Chemother; 2006 Aug; 50(8):2719-27. PubMed ID: 16870764
[TBL] [Abstract][Full Text] [Related]
9. Killing rates for caspofungin against Candida albicans after brief and continuous caspofungin exposure in the presence and absence of serum.
Kovács R; Gesztelyi R; Perlin DS; Kardos G; Domán M; Berényi R; Majoros L
Mycopathologia; 2014 Oct; 178(3-4):197-206. PubMed ID: 25118874
[TBL] [Abstract][Full Text] [Related]
10. Characterising the post-antifungal effects of micafungin against Candida albicans, Candida glabrata, Candida parapsilosis and Candida krusei isolates.
Nguyen KT; Ta P; Hoang BT; Cheng S; Hao B; Nguyen MH; Clancy CJ
Int J Antimicrob Agents; 2010 Jan; 35(1):80-4. PubMed ID: 19889519
[TBL] [Abstract][Full Text] [Related]
11. Five-minute exposure to caspofungin results in prolonged postantifungal effects and eliminates the paradoxical growth of Candida albicans.
Shields RK; Nguyen MH; Press EG; Clancy CJ
Antimicrob Agents Chemother; 2011 Jul; 55(7):3598-602. PubMed ID: 21537017
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Oliveira ER; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; Redding SW
Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
[TBL] [Abstract][Full Text] [Related]
14. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
15. Postantifungal effect of micafungin against Candida albicans, Candida dubliniensis and Candida africana in the presence and absence of serum.
Kardos T; Saleh Q; Kovács R; Gesztelyi R; Kardos G; Bozó A; Tóth Z; Majoros L
New Microbiol; 2017 Oct; 40(4):286-288. PubMed ID: 28994449
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus].
Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
[TBL] [Abstract][Full Text] [Related]
20. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
